IPIX (Innovation Pharmaceuticals) Market Cap: $0.16 Mil (As of Jun. 25, 2026)


What is Innovation Pharmaceuticals Market Cap?

Innovation Pharmaceuticals IPIX Market Cap is $0.16 Mil as of Jun. 25, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Innovation Pharmaceuticals's share price for the quarter that ended in Sep. 2023 was $0.012. Innovation Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 518.35 Mil. Therefore, Innovation Pharmaceuticals's market cap for the quarter that ended in Sep. 2023 was $6.22 Mil.

Innovation Pharmaceuticals's quarterly market cap increased from Mar. 2023 ($10.32 Mil) to Jun. 2023 ($10.37 Mil) but then declined from Jun. 2023 ($10.37 Mil) to Sep. 2023 ($6.22 Mil).

Innovation Pharmaceuticals's annual market cap declined from Jun. 2021 ($93.48 Mil) to Jun. 2022 ($15.62 Mil) and declined from Jun. 2022 ($15.62 Mil) to Jun. 2023 ($10.37 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Innovation Pharmaceuticals's Enterprise Value for Today is $-0.21 Mil.

Innovation Pharmaceuticals  (OTCPK:IPIX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Innovation Pharmaceuticals Market Cap Related Terms

Innovation Pharmaceuticals Market Cap Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Market Cap Chart

Innovation Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.02 134.05 93.48 15.62 10.37

Innovation Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.83 9.36 10.32 10.37 6.22

IPIX vs AXIM, RNAZ, APTX: Market Cap Comparison

For the Biotechnology subindustry, Innovation Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovation Pharmaceuticals Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovation Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Innovation Pharmaceuticals's Market Cap falls into.


Innovation Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Innovation Pharmaceuticals's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )=Share Price (A: Jun. 2023 )*Shares Outstanding (EOP) (A: Jun. 2023 )
=$0.02*518.348
=$10.37

Innovation Pharmaceuticals's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=$0.012*518.348
=$6.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.16 Mil mean?
Innovation Pharmaceuticals (IPIX) has a Market Cap of $0.16 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Market Cap too high?
Innovation Pharmaceuticals' current Market Cap is $0.16 Mil. The Biotechnology industry median Market Cap is 117.63. Innovation Pharmaceuticals' value of $0.16 Mil is 99.9% below this industry median.
How does Innovation Pharmaceuticals' Market Cap compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Market Cap of $0.16 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 117.63. Innovation Pharmaceuticals' value of $0.16 Mil is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.63, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innovation Pharmaceuticals's current Market Cap of $0.16 Mil is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Innovation Pharmaceuticals and its competitors. For the Biotechnology industry, the median Market Cap is 117.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovation Pharmaceuticals's current Market Cap is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Market Cap of $0.16 Mil. The current Market Cap is $0.16 Mil and 99.9% below the Biotechnology industry median of 117.63. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Market Cap is $0.16 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.